| 000 | 01324 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514162206.0 | ||
| 264 | 0 | _c20040308 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1046/j.1365-2125.2003.01893.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabiris, N R | |
| 245 | 0 | 0 |
_aPulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cDec 2003 |
||
| 300 |
_a600-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAerosols |
| 650 | 0 | 4 | _aBiodegradation, Environmental |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetered Dose Inhalers |
| 650 | 0 | 4 | _aNebulizers and Vaporizers |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xadministration & dosage |
| 650 | 0 | 4 | _aPowders |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 700 | 1 | _aDolovich, M B | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 56 _gno. 6 _gp. 600-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2125.2003.01893.x _zAvailable from publisher's website |
| 999 |
_c14353465 _d14353465 |
||